Skip to main content

Table 1 Clinicopathologic characteristics of 275 patients included in our study

From: Phosphorylated AKT1 is associated with poor prognosis in esophageal squamous cell carcinoma

Characteristics No. of patients (%)
Sex  
 Male 223 (81.1)
 Female 52 (18.9)
Age (year) (36–78 year; median 57 year)  
 ≤60 180 (65.5)
 <60 95 (34.5)
Tumor location  
 Upper 37 (13.5)
 Middle 175 (63.6)
 Lower 63 (22.9)
Tumor length  
 <5 cm 123 (44.7)
 ≥5 cm 152 (55.3)
Tumor differentiation  
 Well differentiated 26 (9.5)
 Moderately differentiated 184 (66.9)
 Poorly differentiated 65 (23.6)
Pathologic T stage  
 T1 13 (4.7)
 T2 100 (36.4)
 T3 127 (46.2)
 T4 35 (12.7)
Pathologic N stage  
 N0 101 (36.7)
 N1 74 (26.9)
 N2 71 (25.8)
 N3 29 (10.5)
Pathologic TNM stage  
 I 11 (4.0)
 II 120 (43.6)
 III 144 (52.4)
Adjuvant therapy  
 None 106 (38.5)
 Radiotherapy 10 (3.6)
 Chemotherapy 83 (30.2)
 Chemoradiotherapy 50 (18.2)
 Unknown 26 (9.5)